- Home
- USB vs GSK Comparison
USB vs GSK Comparison
Compare USB & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USB
- GSK
- Stock Information
- Founded
- USB 1863
- GSK 1715
- Country
- USB United States
- GSK United Kingdom
- Employees
- USB N/A
- GSK N/A
- Industry
- USB Major Banks
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- USB Finance
- GSK Health Care
- Exchange
- USB Nasdaq
- GSK Nasdaq
- Market Cap
- USB 61.2B
- GSK 71.7B
- IPO Year
- USB N/A
- GSK N/A
- Fundamental
- Price
- USB $39.90
- GSK $37.42
- Analyst Decision
- USB Buy
- GSK Hold
- Analyst Count
- USB 21
- GSK 4
- Target Price
- USB $50.50
- GSK $47.00
- AVG Volume (30 Days)
- USB 13.9M
- GSK 6.2M
- Earning Date
- USB 04-16-2025
- GSK 04-30-2025
- Dividend Yield
- USB 5.01%
- GSK 4.15%
- EPS Growth
- USB 34.12
- GSK N/A
- EPS
- USB 4.04
- GSK 0.78
- Revenue
- USB $25,356,000,000.00
- GSK $39,280,393,592.00
- Revenue This Year
- USB $14.84
- GSK $7.60
- Revenue Next Year
- USB $4.29
- GSK $5.24
- P/E Ratio
- USB $9.88
- GSK $23.31
- Revenue Growth
- USB 0.80
- GSK 3.46
- 52 Week Low
- USB $35.18
- GSK $31.72
- 52 Week High
- USB $53.98
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- USB 49.04
- GSK 54.43
- Support Level
- USB $39.26
- GSK $35.08
- Resistance Level
- USB $41.15
- GSK $36.16
- Average True Range (ATR)
- USB 1.70
- GSK 1.05
- MACD
- USB 0.42
- GSK 0.28
- Stochastic Oscillator
- USB 79.06
- GSK 97.58
About USB U.S. Bancorp
With assets of around $680 billion, U.S. Bancorp is one of the largest regional banks in the US with its footprint in 26 states. The bank's branch network is mostly in midwestern and western markets. U.S. Bancorp has a comprehensive product set, with offerings in retail and commercial banking, credit cards, mortgages, payment services, trust, and wealth services.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.